AU 0664
Latest Information Update: 27 Jun 2002
Price :
$50 *
At a glance
- Originator Mitsubishi Pharma Corporation
- Class
- Mechanism of Action Chymase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atopic dermatitis
Most Recent Events
- 31 Aug 2000 New profile
- 31 Aug 2000 Preclinical development for Atopic dermatitis in Japan (Unknown route)